IMRX
Price
$1.48
Change
-$0.09 (-5.73%)
Updated
May 21 closing price
Capitalization
56.5M
76 days until earnings call
SRRK
Price
$30.72
Change
-$0.82 (-2.60%)
Updated
May 21 closing price
Capitalization
2.92B
76 days until earnings call
Interact to see
Advertisement

IMRX vs SRRK

Header iconIMRX vs SRRK Comparison
Open Charts IMRX vs SRRKBanner chart's image
Immuneering
Price$1.48
Change-$0.09 (-5.73%)
Volume$192.1K
Capitalization56.5M
Scholar Rock Holding
Price$30.72
Change-$0.82 (-2.60%)
Volume$891.92K
Capitalization2.92B
IMRX vs SRRK Comparison Chart
Loading...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRX vs. SRRK commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRX is a Buy and SRRK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (IMRX: $1.48 vs. SRRK: $30.72)
Brand notoriety: IMRX and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRX: 99% vs. SRRK: 68%
Market capitalization -- IMRX: $56.5M vs. SRRK: $2.92B
IMRX [@Biotechnology] is valued at $56.5M. SRRK’s [@Biotechnology] market capitalization is $2.92B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRX’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • IMRX’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, SRRK is a better buy in the long-term than IMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRX’s TA Score shows that 4 TA indicator(s) are bullish while SRRK’s TA Score has 3 bullish TA indicator(s).

  • IMRX’s TA Score: 4 bullish, 4 bearish.
  • SRRK’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IMRX is a better buy in the short-term than SRRK.

Price Growth

IMRX (@Biotechnology) experienced а +17.46% price change this week, while SRRK (@Biotechnology) price change was +0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

IMRX is expected to report earnings on Aug 06, 2025.

SRRK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($2.92B) has a higher market cap than IMRX($56.5M). SRRK YTD gains are higher at: -28.922 vs. IMRX (-32.727). IMRX has higher annual earnings (EBITDA): -63.85M vs. SRRK (-250.12M). SRRK has more cash in the bank: 437M vs. IMRX (35.9M). IMRX has less debt than SRRK: IMRX (4.08M) vs SRRK (65.1M). IMRX (0) and SRRK (0) have equivalent revenues.
IMRXSRRKIMRX / SRRK
Capitalization56.5M2.92B2%
EBITDA-63.85M-250.12M26%
Gain YTD-32.727-28.922113%
P/E RatioN/AN/A-
Revenue00-
Total Cash35.9M437M8%
Total Debt4.08M65.1M6%
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMRXSRRK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 15 days ago
84%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSYEX56.42N/A
N/A
Victory RS Small Cap Growth Y
FRVLX53.55N/A
N/A
Franklin Small Cap Value A
HFAEX15.12N/A
N/A
Hartford Schroders Intl Cntrrn Val C
RINTX47.09-0.28
-0.59%
Russell Inv International Devd Mkts S
RWICX66.54-0.70
-1.04%
American Funds Capital World Gr&Inc R3

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with NUVL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
-5.73%
NUVL - IMRX
41%
Loosely correlated
-2.93%
INSM - IMRX
30%
Poorly correlated
-3.63%
ORMP - IMRX
29%
Poorly correlated
-1.86%
SRRK - IMRX
29%
Poorly correlated
-2.60%
GOSS - IMRX
29%
Poorly correlated
-2.54%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-2.60%
ORMP - SRRK
42%
Loosely correlated
-1.86%
PLRX - SRRK
41%
Loosely correlated
-2.92%
ONCY - SRRK
41%
Loosely correlated
-2.02%
VTGN - SRRK
40%
Loosely correlated
-7.60%
SNDX - SRRK
39%
Loosely correlated
+0.76%
More